ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,279Medicare Part D Prescriptions Filled, Including Refills

Rank: 167 out of 1454

$787K Total Retail Price of All Prescriptions

Rank: 179 out of 1454

537 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 537 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 537 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 12,971 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
LEVOTHYROXINE SODIUM 635 617 1 5
SIMVASTATIN 608 548 2 1
AMLODIPINE BESYLATE 473 470 3 2
OMEPRAZOLE 443 413 4 3
LISINOPRIL 410 352 5 4
PRAVASTATIN SODIUM 370 317 6 12
HYDROCODONE-ACETAMINOPHEN 354 321 S3 7 7
LOSARTAN POTASSIUM 323 323 8 14
LOSARTAN-HYDROCHLOROTHIAZIDE 323 316 8 38
METFORMIN HCL 321 296 10 8
ATORVASTATIN CALCIUM 320 270 11 11
ZOLPIDEM TARTRATE 320 296 11 19
GABAPENTIN 274 244 13 16
CITALOPRAM HBR 264 224 14 21
GLIMEPIRIDE 246 235 15 33
NEXIUM 242 181 16 23
FUROSEMIDE 225 211 17 6
METOPROLOL TARTRATE 191 191 18 10
CRESTOR 185 166 19 22
ATENOLOL 175 175 20 18
WARFARIN SODIUM 165 165 21 17
POTASSIUM CHLORIDE 157 152 22 15
TAMSULOSIN HCL 151 137 23 34
LISINOPRIL-HYDROCHLOROTHIAZIDE 143 124 24 27
CARVEDILOL 143 136 24 24
TRAMADOL HCL 134 119 26 20
SYNTHROID 132 125 27 25
ROPINIROLE HCL 129 125 28 96
HYDROCHLOROTHIAZIDE 124 118 29 9
LOVASTATIN 121 108 30 39
CLOPIDOGREL 120 116 31 32
ALLOPURINOL 117 114 32 28
BYSTOLIC 113 113 33 110
PANTOPRAZOLE SODIUM 110 102 34 31
METOPROLOL SUCCINATE 105 105 35 13
ALENDRONATE SODIUM 101 86 36 35
ADVAIR DISKUS 100 80 37 47
AZITHROMYCIN 98 90 38 42
NAPROXEN 96 84 39 122
PLAVIX 95 89 40 45
MELOXICAM 91 77 41 37
DIOVAN HCT 88 88 42 75
DILTIAZEM 24HR ER 85 85 43 120
FLUTICASONE PROPIONATE 84 62 44 30
SOTALOL 82 82 45 253
ESTRADIOL 81 81 R 46 164
GLIPIZIDE 78 67 47 62
FENOFIBRATE 77 75 48 68
VESICARE 70 60 49 199
CELEBREX 68 58 50 81
PAROXETINE HCL 66 51 51 73
CYMBALTA 64 42 52 55
LIPITOR 63 63 53 74
CLONIDINE HCL 61 61 54 49
PROAIR HFA 61 58 54 56
DILTIAZEM 24HR CD 59 55 56 76
NIASPAN 59 59 56 117
CARISOPRODOL 57 0 R 58 123
LEVOXYL 57 57 58 84
SPIRONOLACTONE 56 53 60 63
ISOSORBIDE MONONITRATE ER 55 51 61 46
LYRICA 55 55 61 103
ESCITALOPRAM OXALATE 54 44 63 78
NIFEDIPINE ER 51 23 64 102
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.